Silver Book Fact

Timely treatment and follow-up care can reduce the risk of blindness in individuals with proliferative retinopathy by 95%.

Diabetic Retinopathy. www.rpbusa.org/dr.php

Reference

Title
Diabetic Retinopathy
Authors
Research to Prevent Blindness
URL
Read Full Resource

Categories

  • Innovative Medical Research
  • Human Value

Related Facts

  • After 9 years of tight blood pressure control, patients with type 2 diabetes had a 34% reduction in retinopathy progression and a 47% reduction in risk of visual acuity deterioration…  
  • Cytokines in urine are associated with age-related macular degeneration (AMD) and could be developed as a biomarker and provide a practical tool for early detection  
  • Macugen to treat wet age-related macular degeneration (AMD)
    A new FDA-approved ophthalmic drug that treats wet age-related macular degeneration (AMD)– pegaptanib sodium (Macugen)– reduced vision loss in 70% of clinical trial patients.  
  • Nearly 50% of diabetic retinopathy patients who received ranibizumab–an anti-VEGF drug–experienced substantial visual improvement after a year of injections  
  • Intensive glucose control (3 or more daily insulin injections or continuous subcutaneous insulin infusion) reduced the mean risk of retinopathy by 76% in type 1 diabetes patients who had not…